THANK YOU FOR SUBSCRIBING
Pharmaceutical companies are trying to adopt patient-facing digital technologies (PT) for clinical trials.
FREMONT, CA; The patient-facing digital technologies (PT) consist of digital technologies like wearable devices, sensors, and software that can communicate with people to participate in healthcare and clinical trials. If the technologies are applied accurately, it will allow to collect data, increase access timely, offer quality care, and enhance the patient experience.
PT is not a new concept, but its implementation in clinical trials has not been entirely explored due to various logistical issues. The connection between clinical trials and PT will increase patients' participation, enhance outcome measures, and help collect real-world data. However, the advantages of applying PT in clinical studies are clear. However, it has to make a straightforward entry into the clinical area because many trials are still dependent on the traditional research method.
Initiative Addresses Barriers in Adoption Of PT
Even though there is some uncertainty with PT, there is an increasing interest in its utilization in clinical trials because it can decrease the patient's burden. Therefore, to understands the factors related to PT, and researchers have conducted a series of interviews, surveys, and questionnaires. It also consists of clinical trial investigators, clinical trial participants, and pharmaceutical company representatives. There are also general views about the value of patient-facing technology as a clinical research tool, even though there are different types of difficulties that have been faced by every identified stakeholder.
However, two significant factors creating issues in adopting PT in clinical trials are organizational and external challenges. The organizational issues consist of regional differences in technological usage, the extra expense, and risks related to changing procedures and adverse corporate culture. The corporate culture can create issues because of the speed at which technologies are being developed worldwide. There can also be regional differences in thoughts, approaches towards technology, and interpretations, making its adoption extremely difficult.
In response to recently looked into issues, Patient Technology Toolkit was developed, which can be used by the industry stakeholders. It is also designed to serve as a useful framework to implement PT in clinical trials. The toolkit can also help them identify and prevent the risks related to PT's adoption and make communication easier among internal and external stakeholders.
See Also: Top Patient Monitoring Solution Companies